definiens: shall mean the Seller ’s CDAD program including any and all of the following ass ets of the Seller, including any and all rights and ben efits constituting and relating to the Seller 's β - l actamase technology and all other biomedical or pharmaceutic al technologies of the Seller and all β - lactamase p roducts detained and/or developed with the aforementioned t echnologies, including without limitation the lead P1A, P2A and P3A - based products in preclinical and clinical phases ( the ) and all tangible and intangi ble intellectual property and know how exclusively rela ted thereto including the following : 1 Portions herein identified by [ * * * * * ] have been omi tted pursuant to a request for confidential treatme nt under Rule 24b- 2 of the Securities Exchange Act of 1934, as amende d. A complete copy of this document has been filed separately with the Securities and E xchange Commission